<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2125</journal-id>
<journal-title><![CDATA[Revista Cubana de Medicina General Integral]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Med Gen Integr]]></abbrev-journal-title>
<issn>0864-2125</issn>
<publisher>
<publisher-name><![CDATA[ECIMED]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21252019000300010</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Miopatía distal de tipo Miyoshi]]></article-title>
<article-title xml:lang="en"><![CDATA[Miyoshi Type´s distal myopathy]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Creagh Bandera]]></surname>
<given-names><![CDATA[Idalberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Ferreiro]]></surname>
<given-names><![CDATA[Yanet Del Carmen]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morocho Rosero]]></surname>
<given-names><![CDATA[Karla Cecilia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Policlínico Asdrubal López  ]]></institution>
<addr-line><![CDATA[Guantánamo ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Policlínico Emilio Daudinot  ]]></institution>
<addr-line><![CDATA[Guantánamo ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Duran  ]]></institution>
<addr-line><![CDATA[Guayaquil ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2019</year>
</pub-date>
<volume>35</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21252019000300010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21252019000300010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21252019000300010&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La distrofia muscular a tipo Miyoshi es una enfermedad genética, neuromuscular que afecta a las cinturas escapular y pélvica, causando alto grado de discapacidad, su diagnóstico se realiza a través de exámenes enzimáticos y biopsia muscular.  Caso clínico: Paciente de 48 años de edad con una evolución de su diagnóstico de hace 16 años, con gran limitación funcional para la marcha desde hace un año y medio, debilidad muscular y atrofia de la musculatura posterior de ambos miembros inferiores. Se le realizó tratamiento rehabilitador integral con objetivos específicos.  Conclusiones:  Luego de 30 sesiones de tratamiento, se cumplieron los objetivos trazados con evolución satisfactoria, siendo el tratamiento rehabilitador integral un pilar importante en la mejoría clínica del paciente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Muscular dystrophy of Miyoshi type is a genetic and neuromuscular disease that affects the pelvic and shoulder girdle and causes high degree of disability. Its diagnosis is through enzyme testing and muscle biopsy.  Clinical case:  48- years- male patient with evolution of his diagnosis made 16 years ago. The patient had great functional limitation for walking from a year and a half before, muscle weakness and atrophy of the posterior muscles of both lower limbs. It was applied comprehensive rehabilitation treatment with specific objectives.  Conclusions:  After 30 treatment sessions, the objectives were achieved with a satisfactory evolution. The comprehensive rehabilitative treatment proved to be an important pillar in the patient´s clinical improvement.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Distrofia muscular]]></kwd>
<kwd lng="es"><![CDATA[discapacidad]]></kwd>
<kwd lng="es"><![CDATA[rehabilitación]]></kwd>
<kwd lng="en"><![CDATA[Muscular Dystrophy]]></kwd>
<kwd lng="en"><![CDATA[disability]]></kwd>
<kwd lng="en"><![CDATA[rehabilitation]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erazo-Torricelli]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización en distrofias musculares]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2004</year>
<volume>39</volume>
<page-range>860-71</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frosk]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Weiler]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Nylen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sudha]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Greenberg]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Morgan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3- ubiquitin-ligase gene]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2012</year>
<volume>70</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>663-72</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mayans]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Structural basis for activation of the titinkinasedomain during myofibrillogenesis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Van der Ven]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
<name>
<surname><![CDATA[Wilm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mues]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Fürst]]></surname>
<given-names><![CDATA[DO]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature]]></source>
<year>1998</year>
<volume>395</volume>
<numero>6705</numero>
<issue>6705</issue>
<page-range>863-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wehnert]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Bonne]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The nuclear muscular dystrophies]]></article-title>
<source><![CDATA[Semin Pediatr Neurol]]></source>
<year>2012</year>
<volume>9</volume>
<page-range>100-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fairley]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Kendrick-Jones]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ellis]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: animmunopathological study]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[The Eme Confalonieri]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Oliva]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Andreetta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[J Neuroimmunol]]></source>
<year>2013</year>
<volume>142</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>130-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bornemann]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic protein expression in human muscle biopsies]]></article-title>
<source><![CDATA[Brain Pathol]]></source>
<year>2000</year>
<volume>10</volume>
<page-range>193-214</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shuk]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Vilquin]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Tremblay]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experimental and therapeutic approaches to muscular dystrophies]]></article-title>
<source><![CDATA[Curr Opin Neurol]]></source>
<year>2012</year>
<volume>15</volume>
<page-range>563-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Emery]]></surname>
<given-names><![CDATA[AEH]]></given-names>
</name>
<name>
<surname><![CDATA[Dreyfuss]]></surname>
<given-names><![CDATA[FE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unusual type of bening X- linked muscular dystrophy]]></article-title>
<source><![CDATA[J Neurol Neurosurg Psychiatry]]></source>
<year>1966</year>
<volume>29</volume>
<page-range>338</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aragon]]></surname>
<given-names><![CDATA[Asem]]></given-names>
</name>
</person-group>
<source><![CDATA[Miopatía distal tipo Miyoshi]]></source>
<year>2013</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>201</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Hernández]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Ayala-Madrigal]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[van Heudsen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Estrada-Mena]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Canto]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sandóval-Ramírez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mejoras en el diagnóstico de distrofinopatías ¿qué hemos aprendido después de 20 años?]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2010</year>
<volume>52</volume>
<page-range>239-49</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
